2invest AG is a listed company that acquires, holds, manages and sells investments in corporations and partnerships, in particular – but not exclusively – in the biotechnology, life science and IT sectors in Germany and abroad.
Global investments or investments in unlisted companies or financial instruments are also possible. Investment decisions are made on the basis of attractive risk-reward profiles. The focus is on achieving a risk-adequate, long-term total return.
The company is listed in the Prime Standard of the Frankfurt Stock Exchange (Ticker: 2INV; ISIN: DE000A3H3L44).